During the past decade, Clinical Hospital Center Bezanijska Kosa conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 46 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 33 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Center Bezanijska Kosa" #1 sponsor was "Hoffmann-La Roche" with 21 trials, followed by "Shire" with 9 trials sponsored, "Celgene" with 8 trials sponsored, "Takeda" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Center Bezanijska Kosa" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "BioGene Pharmaceutical Inc." with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Center Bezanijska Kosa" are "Ulcerative Colitis" (17 trials), "Crohn's Disease" (14 trials), "Crohn Disease" (8 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Clinical Hospital Center Bezanijska Kosa" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Center Bezanijska Kosa" are "Drug" (94 trials), "Other" (9 trials), "Biological" (7 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Carboplatin" (13 trials), "Atezolizumab" (7 trials), "Paclitaxel" (6 trials) and "Pemetrexed" (6 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Center Bezanijska Kosa" are 102 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Hospital Center Bezanijska Kosa". undefined are not yet recruiting, 18 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in Clinical Hospital Center Bezanijska Kosa, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Center Bezanijska Kosa, 5 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".